To reduce Bundibugyo Virus Disease and prevent avoidable illness and death in the Democratic Republic of the Congo, Uganda, and at-risk countries through end-to-end procurement of critical therapeutics, diagnostics, and medical supplies
- Funded by Gates Foundation
- Total publications:0 publications
Grant number: INV-108745
Grant search
Key facts
Disease
EbolaStart & end year
20262027Known Financial Commitments (USD)
$5,000,000Funder
Gates FoundationResearch Location
180; 800Lead Research Institution
World Health OrganizationResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
DiagnosticsSpecial Interest Tags
N/AStudy Type
Not applicableClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
To reduce Bundibugyo Virus Disease and prevent avoidable illness and death in the Democratic Republic of the Congo, Uganda, and at-risk countries through end-to-end procurement of critical therapeutics, diagnostics, and medical supplies